Neurofibromatosis-Noonan syndrome (NFNS) is a distinct entity which shows the features of both NF1 (neurofibromatosis 1) and Noonan syndrome (NS). While growth hormone deficiency (GHD) has been relatively frequently identified in NF1 and NS patients, there is limited experience in NFNS cases. The literature includes only one case report of a NFNS patient having GHD and that report primarily focuses on the dermatological lesions that accompany the syndrome and not on growth hormone (GH) treatment. Here, we present a 13-year-old girl who had clinical features of NFNS with a mutation in the NF1 gene. The case is the first NFNS patient reported in the literature who was diagnosed to have GHD and who received GH treatment until reaching final he...
Neurofibromatosis type 1 (NF1) is one of the most frequent genetic disorders, affecting 1:3,000 worl...
Background: Noonan Syndrome (NS) is an autosomal dominant disorder characterized by short stature, d...
Introduction: Noonan syndrome (NS) is caused by mutations in RAS/MAPK signalling pathway genes. Grow...
Background. Growth hormone (GH) treatment increases the adult height of short children born small fo...
Noonan syndrome (NS) is an autosomal dominant disorder that involves multiple organ systems, with sh...
case reportNeurofibromatosis–Noonan syndrome is a rare autosomal dominant disorder which combines ne...
BACKGROUND: Noonan syndrome (NS) is an autosomal dominant disorder characterized by specific featur...
Objective: Noonan syndrome (NS) is a multisystem disorder, and short stature is its most striking ma...
Noonan-like syndrome with loose anagen hair (NS/LAH; OMIM 607721), recently related to the invariant...
Noonan-like syndrome with loose anagen hair (NS/LAH; OMIM 607721), recently related to the invariant...
The role of GH insufficiency in the pathogenesis of short stature in Noonan syndrome is unclear. Cro...
Neurofibromatosis type 1 (NF1) is one of the most frequent genetic disorders, affecting 1:3,000 worl...
BACKGROUND Noonan syndrome (NS) is an autosomal dominant disorder characterised by genotypic and phe...
0Objective: Noonan syndrome (NS) is a multisystem disorder, and short stature is its most striking m...
Noonan-like syndrome with loose anagen hair (NS/LAH; OMIM #607721) has been recently related to the ...
Neurofibromatosis type 1 (NF1) is one of the most frequent genetic disorders, affecting 1:3,000 worl...
Background: Noonan Syndrome (NS) is an autosomal dominant disorder characterized by short stature, d...
Introduction: Noonan syndrome (NS) is caused by mutations in RAS/MAPK signalling pathway genes. Grow...
Background. Growth hormone (GH) treatment increases the adult height of short children born small fo...
Noonan syndrome (NS) is an autosomal dominant disorder that involves multiple organ systems, with sh...
case reportNeurofibromatosis–Noonan syndrome is a rare autosomal dominant disorder which combines ne...
BACKGROUND: Noonan syndrome (NS) is an autosomal dominant disorder characterized by specific featur...
Objective: Noonan syndrome (NS) is a multisystem disorder, and short stature is its most striking ma...
Noonan-like syndrome with loose anagen hair (NS/LAH; OMIM 607721), recently related to the invariant...
Noonan-like syndrome with loose anagen hair (NS/LAH; OMIM 607721), recently related to the invariant...
The role of GH insufficiency in the pathogenesis of short stature in Noonan syndrome is unclear. Cro...
Neurofibromatosis type 1 (NF1) is one of the most frequent genetic disorders, affecting 1:3,000 worl...
BACKGROUND Noonan syndrome (NS) is an autosomal dominant disorder characterised by genotypic and phe...
0Objective: Noonan syndrome (NS) is a multisystem disorder, and short stature is its most striking m...
Noonan-like syndrome with loose anagen hair (NS/LAH; OMIM #607721) has been recently related to the ...
Neurofibromatosis type 1 (NF1) is one of the most frequent genetic disorders, affecting 1:3,000 worl...
Background: Noonan Syndrome (NS) is an autosomal dominant disorder characterized by short stature, d...
Introduction: Noonan syndrome (NS) is caused by mutations in RAS/MAPK signalling pathway genes. Grow...